Clinical trial
RH Genotype Matched Red Cells for Patients With Sickle Cell Disease and Anti-D
NCT04156906 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RH Genotype Matched Red Cells for Patients With Sickle Cell Disease and Anti-D
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 8, 2020
- Completion date
- October 4, 2024
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anti-d antibodies, sickle cell disease